Douglass Winthrop Advisors, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Douglass Winthrop Advisors, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2020$1,655,000
+48.2%
28,995
+63.4%
0.05%
+30.6%
Q3 2020$1,117,000
+42.8%
17,746
+31.3%
0.04%
+24.1%
Q2 2020$782,000
+49.5%
13,520
+17.6%
0.03%
+26.1%
Q1 2020$523,000
-2.8%
11,497
+4.4%
0.02%
+21.1%
Q4 2019$538,000
+58.7%
11,013
+36.6%
0.02%
+46.2%
Q3 2019$339,000
+5.6%
8,063
+16.8%
0.01%0.0%
Q2 2019$321,000
-1.2%
6,902
-2.4%
0.01%
-7.1%
Q1 2019$325,000
+0.9%
7,069
-1.6%
0.01%
-12.5%
Q4 2018$322,000
+58.6%
7,185
+93.8%
0.02%
+77.8%
Q3 2018$203,0003,7070.01%
Other shareholders
Novozymes A/S shareholders Q4 2020
NameSharesValueWeighting ↓
ZEVIN ASSET MANAGEMENT LLC 57,209$2,8870.63%
Boston Common Asset Management, LLC 18,413$9300.04%
GOFEN & GLOSSBERG LLC /IL/ 5,000$2520.01%
MAR VISTA INVESTMENT PARTNERS LLC 273$13,7760.00%
ST GERMAIN D J CO INC 5,000$2520.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,075$155,2970.00%
Financial Avengers, Inc. 10$5050.00%
View complete list of Novozymes A/S shareholders